CNBC: Investing
SEPTEMBER 16, 2023
Guggenheim analyst Seamus Fernandez said the total addressable market for GLP-1 drugs like Ozempic and Wegovy could balloon to $150 billion to $200 billion.
The New York Times: Banking
SEPTEMBER 16, 2023
Stocks are mired in a holding pattern. The big question, our columnist says, is when will the Federal Reserve start to cut interest rates?
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
CNBC: Investing
SEPTEMBER 16, 2023
The Gilman Hill Asset Management CEO revealed to CNBC's "Art of the Trade" that her best trade ever is all about slow and steady.
CNBC: Investing
SEPTEMBER 16, 2023
Elliott recently entered a cooperation agreement with Catalent. This could pave the way for some major changes at the pharmaceutical company.
Advertisement
Generative AI is upending the way product developers & end-users alike are interacting with data. Despite the potential of AI, many are left with questions about the future of product development: How will AI impact my business and contribute to its success? What can product managers and developers expect in the future with the widespread adoption of AI?
CNBC: Investing
SEPTEMBER 16, 2023
Wall Street analysts said this week there's a host of stocks that are positioned to profit from artificial intelligence.
Expert insights. Personalized for you.
127 
Let's personalize your content